RU93053632A - Стероидные эфиры, способ их получения, фармацевтическая композиция и способ лечения воспалительных и аллергических заболеваний - Google Patents
Стероидные эфиры, способ их получения, фармацевтическая композиция и способ лечения воспалительных и аллергических заболеванийInfo
- Publication number
- RU93053632A RU93053632A RU93053632/04A RU93053632A RU93053632A RU 93053632 A RU93053632 A RU 93053632A RU 93053632/04 A RU93053632/04 A RU 93053632/04A RU 93053632 A RU93053632 A RU 93053632A RU 93053632 A RU93053632 A RU 93053632A
- Authority
- RU
- Russia
- Prior art keywords
- hydrogen
- producing
- allergic diseases
- pharmaceutical composition
- compounds
- Prior art date
Links
- -1 STEROID ETHERS Chemical class 0.000 title 1
- 230000000172 allergic Effects 0.000 title 1
- 201000008937 atopic dermatitis Diseases 0.000 title 1
- 230000002757 inflammatory Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 4
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (1)
- Предложены соединения с общей формулой I; в этой формуле 1,2-положение является насыщенным или представляет собой двойную связь, R1 является водородом или же прямой или разветвленной углеводородной цепью, R2 является водородом или же прямой или разветвленной углеводородной цепью, R3 является ацилом, X1 является водородом или галогеном, X2 является водородом или галогеном при условии, что 1) R1 и R2 одновременно не являются водородом, 2) Х1 и Х2 одновременно не являются водородом, 3) если 1,2-положение представляет собой двойную связь R1 и R2 одновременно не являются метильными группами, 4) если 1,2-положение представляет собой двойную связь, R1 является атомом водорода и R2 является прямой или разветвленной углеводородной цепью, имеющей 1-10 атомов углерода, R3 является ацилом, имеющим 11-20 атомов углерода; способы получения этих соединений, фармацевтические препараты, содержащие эти соединения и использование этих соединений для лечения воспалительных и аллергических заболеваний.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9100342A SE9100342D0 (sv) | 1991-02-04 | 1991-02-04 | Novel steroid esters |
SE9100342-06 | 1991-02-04 | ||
SE9100342-6 | 1991-02-04 | ||
PCT/SE1992/000056 WO1992013873A1 (en) | 1991-02-04 | 1992-01-29 | Novel steroid esters |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93053632A true RU93053632A (ru) | 1997-01-20 |
RU2112775C1 RU2112775C1 (ru) | 1998-06-10 |
Family
ID=20381807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93053632A RU2112775C1 (ru) | 1991-02-04 | 1992-01-29 | Стероидные эфиры или их стереоизомеры, способ их получения, фармацевтическая композиция |
Country Status (38)
Country | Link |
---|---|
US (1) | US5614514A (ru) |
EP (1) | EP0572451B1 (ru) |
JP (1) | JP2947933B2 (ru) |
KR (1) | KR100205835B1 (ru) |
CN (3) | CN1039329C (ru) |
AP (1) | AP365A (ru) |
AT (1) | ATE164589T1 (ru) |
BG (1) | BG61816B1 (ru) |
CA (1) | CA2100453A1 (ru) |
CZ (1) | CZ282057B6 (ru) |
DE (1) | DE69224982T2 (ru) |
DK (1) | DK0572451T3 (ru) |
DZ (1) | DZ1554A1 (ru) |
EE (1) | EE03110B1 (ru) |
ES (1) | ES2114931T3 (ru) |
FI (1) | FI933451A0 (ru) |
HK (1) | HK1004335A1 (ru) |
HU (1) | HU221168B1 (ru) |
IE (1) | IE920167A1 (ru) |
IL (1) | IL100542A (ru) |
IS (1) | IS1653B (ru) |
MA (1) | MA22407A1 (ru) |
MX (1) | MX9200374A (ru) |
MY (1) | MY111502A (ru) |
NO (1) | NO304074B1 (ru) |
NZ (1) | NZ241211A (ru) |
PL (1) | PL170383B1 (ru) |
PT (1) | PT100087B (ru) |
RO (1) | RO111272B1 (ru) |
RU (1) | RU2112775C1 (ru) |
SE (1) | SE9100342D0 (ru) |
SK (1) | SK281802B6 (ru) |
TN (1) | TNSN92008A1 (ru) |
TW (1) | TW287166B (ru) |
UA (1) | UA43825C2 (ru) |
WO (1) | WO1992013873A1 (ru) |
YU (1) | YU48893B (ru) |
ZA (1) | ZA92234B (ru) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9100341D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroids |
RU95115547A (ru) * | 1993-01-08 | 1997-06-10 | Астра Актиеболаг (SE) | Стероидные соединения, способы их получения и фармацевтический препарат |
US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
US5980949A (en) * | 1994-10-03 | 1999-11-09 | Astra Aktiebolag | Formulation for inhalation |
SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
AU4093799A (en) | 1998-05-22 | 1999-12-13 | Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
CA2371689C (en) | 1999-05-27 | 2012-06-26 | Wolfgang Fleischer | Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatment |
HRP20010018A2 (en) | 2001-01-09 | 2002-12-31 | Pliva D D | Novel anti-inflammatory compounds |
US20050009798A1 (en) * | 2002-02-20 | 2005-01-13 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists |
AU2003217535A1 (en) * | 2002-02-20 | 2003-09-09 | Sepracor Inc. | Carbonate and carbamate modified forms of glucocorticoids |
US7091187B2 (en) | 2002-07-08 | 2006-08-15 | Pliva-Istrazivacki Institut D.O.O. | Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
WO2004005313A2 (en) | 2002-07-08 | 2004-01-15 | Pliva - Istrazivacki Institut D.O.O. | Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
EP1562627A4 (en) * | 2002-08-23 | 2006-11-02 | Mclean Hospital Corp | CORTICOSTEROID CONJUGATES AND ITS USES |
WO2004033478A2 (en) * | 2002-10-08 | 2004-04-22 | Sepracor Inc. | Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
HRP20030324A2 (en) | 2003-04-24 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | Compounds of antiinflammatory effect |
HRP20030604A2 (en) | 2003-07-25 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | Substituted furochromenes, preparation thereof andtheir antiinflammatory action |
HRP20030603A2 (en) | 2003-07-25 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Substituted furochromene compounds of antiinflammatory action |
WO2005016352A1 (en) * | 2003-08-05 | 2005-02-24 | Sepracor Inc. | AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ß2 ADRENERGIC AGONISTS |
DE602005018672D1 (de) | 2004-10-27 | 2010-02-11 | Glaxosmithkline Zagreb | Konjugate mit entzündungshemmender aktivität |
PT1889198E (pt) | 2005-04-28 | 2015-03-06 | Proteus Digital Health Inc | Sistema fármaco-informático |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
US8737506B1 (en) | 2010-12-29 | 2014-05-27 | Sprint Communications Company L.P. | Determination of transmit diversity transmission delays |
US8437713B1 (en) | 2011-02-16 | 2013-05-07 | Sprint Communications Company L.P. | Wireless transmit diversity control by location of a wireless communication device |
US8565686B2 (en) | 2011-06-30 | 2013-10-22 | Sprint Communications Company L.P. | Power status multipath search window sizing for wireless communications |
JP6231995B2 (ja) | 2012-02-10 | 2017-11-15 | タイワン リポソーム カンパニー リミテッド | 眼の疾患の合併症を低減するための薬学的組成物 |
JP5965187B2 (ja) * | 2012-03-30 | 2016-08-03 | 小林製薬株式会社 | 油性軟膏剤 |
CN109985048B (zh) * | 2017-12-29 | 2021-06-29 | 广州市赛普特医药科技股份有限公司 | 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3126375A (en) * | 1964-03-24 | Chioacyl | ||
US3197469A (en) * | 1958-08-06 | 1965-07-27 | Pharmaceutical Res Products In | 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor |
US3048581A (en) * | 1960-04-25 | 1962-08-07 | Olin Mathieson | Acetals and ketals of 16, 17-dihydroxy steroids |
US3357974A (en) * | 1965-12-28 | 1967-12-12 | Merck & Co Inc | Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones |
US3758686A (en) * | 1971-12-07 | 1973-09-11 | American Cyanamid Co | Method of using steroid acetonides |
SE378109B (ru) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
US3796701A (en) * | 1973-02-26 | 1974-03-12 | Squibb & Sons Inc | 5alpha,9-oxazino steroids and 9-carboxamido steroids |
SE8008524L (sv) * | 1980-12-04 | 1982-06-05 | Draco Ab | 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand |
US4304727A (en) * | 1980-12-05 | 1981-12-08 | The Upjohn Company | 9α-Debromination |
JPS58176485A (ja) * | 1982-04-08 | 1983-10-15 | Nippon Denso Co Ltd | 可変容量圧縮機 |
US4749649A (en) * | 1983-05-16 | 1988-06-07 | The Upjohn Company | Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen |
JPS6067496A (ja) * | 1983-09-26 | 1985-04-17 | Ota Seiyaku Kk | フルオシノロン16,17−アセトニド21−ブチレ−トおよびその製造法 |
IT1196142B (it) * | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
SE8403905D0 (sv) * | 1984-07-30 | 1984-07-30 | Draco Ab | Liposomes and steroid esters |
-
1991
- 1991-02-04 SE SE9100342A patent/SE9100342D0/xx unknown
- 1991-12-27 IL IL10054291A patent/IL100542A/xx not_active IP Right Cessation
- 1991-12-30 TW TW080110262A patent/TW287166B/zh active
-
1992
- 1992-01-06 NZ NZ241211A patent/NZ241211A/xx unknown
- 1992-01-13 ZA ZA92234A patent/ZA92234B/xx unknown
- 1992-01-21 IE IE016792A patent/IE920167A1/en not_active IP Right Cessation
- 1992-01-22 DZ DZ920006A patent/DZ1554A1/fr active
- 1992-01-22 YU YU6492A patent/YU48893B/sh unknown
- 1992-01-27 AP APAP/P/1992/000354A patent/AP365A/en active
- 1992-01-29 ES ES92904423T patent/ES2114931T3/es not_active Expired - Lifetime
- 1992-01-29 WO PCT/SE1992/000056 patent/WO1992013873A1/en active IP Right Grant
- 1992-01-29 UA UA93004296A patent/UA43825C2/uk unknown
- 1992-01-29 HU HU9302243A patent/HU221168B1/hu not_active IP Right Cessation
- 1992-01-29 MX MX9200374A patent/MX9200374A/es unknown
- 1992-01-29 RU RU93053632A patent/RU2112775C1/ru active
- 1992-01-29 KR KR1019930702299A patent/KR100205835B1/ko not_active IP Right Cessation
- 1992-01-29 DK DK92904423T patent/DK0572451T3/da active
- 1992-01-29 PL PL92300351A patent/PL170383B1/pl unknown
- 1992-01-29 DE DE69224982T patent/DE69224982T2/de not_active Expired - Fee Related
- 1992-01-29 AT AT92904423T patent/ATE164589T1/de not_active IP Right Cessation
- 1992-01-29 US US08/094,100 patent/US5614514A/en not_active Expired - Fee Related
- 1992-01-29 CA CA002100453A patent/CA2100453A1/en not_active Abandoned
- 1992-01-29 EP EP92904423A patent/EP0572451B1/en not_active Expired - Lifetime
- 1992-01-29 CZ CS931495A patent/CZ282057B6/cs not_active IP Right Cessation
- 1992-01-29 JP JP4504217A patent/JP2947933B2/ja not_active Expired - Fee Related
- 1992-01-29 RO RO93-01094A patent/RO111272B1/ro unknown
- 1992-01-29 SK SK797-93A patent/SK281802B6/sk unknown
- 1992-01-31 MY MYPI92000158A patent/MY111502A/en unknown
- 1992-02-03 MA MA22693A patent/MA22407A1/fr unknown
- 1992-02-03 IS IS3809A patent/IS1653B/is unknown
- 1992-02-03 CN CN92100797A patent/CN1039329C/zh not_active Expired - Fee Related
- 1992-02-03 PT PT100087A patent/PT100087B/pt not_active IP Right Cessation
- 1992-02-04 TN TNTNSN92008A patent/TNSN92008A1/fr unknown
-
1993
- 1993-08-02 BG BG98011A patent/BG61816B1/bg unknown
- 1993-08-02 NO NO932762A patent/NO304074B1/no not_active IP Right Cessation
- 1993-08-03 FI FI933451A patent/FI933451A0/fi unknown
-
1994
- 1994-11-23 EE EE9400330A patent/EE03110B1/xx not_active IP Right Cessation
-
1996
- 1996-10-22 CN CN96122759A patent/CN1076607C/zh not_active Expired - Fee Related
- 1996-11-01 CN CN96114411A patent/CN1076606C/zh not_active Expired - Fee Related
-
1998
- 1998-04-24 HK HK98103446A patent/HK1004335A1/xx not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93053632A (ru) | Стероидные эфиры, способ их получения, фармацевтическая композиция и способ лечения воспалительных и аллергических заболеваний | |
SE9100342D0 (sv) | Novel steroid esters | |
ITMI912296A0 (it) | Nuovi pregna 1,4-diene-3,20.dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori | |
DK0804252T3 (da) | Monoamin-, diamid-, thiol-holdige metalchelateringsmidler | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
AU2315288A (en) | Cell growth inhibitors and methods of treating cancer and cell proliferative diseases | |
FR2656609B1 (fr) | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. | |
FR2663331B1 (fr) | Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
IT8420682A1 (it) | "Procedimento per il trattamento di articoli di maglieria" | |
DK0738712T3 (da) | Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning | |
SE436751B (sv) | Forfarande enligt krav 1 i patentet 7613920-3 (publ.nr 423903) for framstellning av 17alfa-acyloxi-9alfa, 21-dihalogen-11beta-hydroxi-6alfa-fluor-16beta-metyl-pregna-1,4-dien-3,20-dion-foreningar | |
PT86228A (de) | Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate | |
NO157655C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater. | |
KR900701273A (ko) | 진토성 에르골린 유도체 | |
FI834136A (fi) | 1-aroyl-5-oxo-2-pyrrolidin-propansyror och mostvarande estrar | |
KR890017363A (ko) | 스트로빌루린 유도체, 이들의 제법 및 용도 | |
FR2448544A1 (fr) | Derives de thiazole et leur application en therapeutique | |
JPS53105451A (en) | Thiourea derivatives, process for their preparation and controlling agents against harmful organisms containing the same | |
NO821083L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater | |
DE69533833D1 (de) | Verfahren zur Herstellung von Indolopyrrolocarbazol-Derivaten | |
IT1145433B (it) | Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione | |
JO1713B1 (en) | Modern fatty acid esters | |
TH11569EX (th) | สเทรอยด์ เอสเทอร์ ชนิดใหม่ | |
ATA407877A (de) | Verfahren zur herstellung neuer derivate des pyrrolo-(1,2-a) (1,4)-diazepines und deren salzen | |
RU94031167A (ru) | Пептиды, обладающие терапевтической активностью, способ их получения, фармацевтическая композиция, способ лечения ожирения |